 |
|
|
| |
Using the F/TDF Adherence-Efficacy Relationship to Calculate
Background HIV Incidence: Results From the DISCOVER Trial
|
| |
| |
IDWeek 2020 Oct 21-25 virtual
Reported by Jules Levin
David V. Glidden,1 David T. Dunn,2 Moupali Das,3 Ramin Ebrahimi,3 Lijie Zhong,3 Oliver T. Stirrup,2 Peter L. Anderson4
1University of California San Francisco; 2UCL Centre for Clinical Research in Infection and Sexual Health, Institute for Global Health, University College London, UK; 3Gilead Sciences, Inc., Foster City, CA; 4University of Colorado Anschutz Medical Campus, Aurora
|
| |
|
|
|
|
|
